Psychedelics are having a moment.
For years, psychedelics were relegated to the fringes of society. But now, these substances are becoming mainstream, with dozens of clinical trials underway testing their potential for treating conditions like depression, anxiety, and PTSD.
This renewed interest in psychedelics is leading to a psychedelics renaissance, with investors pouring millions of dollars into companies developing these drugs.
Why are psychedelics suddenly so popular? And what does this mean for investors? Here's a look at the psychedelics industry and what it could mean for your portfolio.
Psychedelics have long been used for spiritual and therapeutic purposes. In recent years, however, scientists have begun to explore their potential as treatments for mental health conditions.
A number of small clinical trials have shown that psychedelics can be effective in treating conditions like depression, anxiety, and PTSD. What's more, psychedelics seem to have a low risk of abuse and dependence compared to other drugs.
This renewed interest in psychedelics is leading to a psychedelics renaissance, with investors pouring millions of dollars into companies developing these drugs.
Why are psychedelics suddenly so popular? And what does this mean for investors? Here's a look at the psychedelics industry and what it could mean for your portfolio.
Psychedelics have long been used for spiritual and therapeutic purposes. In recent years, however, scientists have begun to explore their potential as treatments for mental health conditions.
A number of small clinical trials have shown that psychedelics can be effective in treating conditions like depression, anxiety, and PTSD. What's more, psychedelics seem to have a low risk of abuse and dependence compared to other drugs.
This renewed interest in psychedelics is leading to a psychedelics renaissance, with investors pouring millions of dollars into companies developing these drugs.
